SCHEMBL9856705

SCHEMBL9856705

CN(C)CCC(Cc1ccccc1C(F)(F)F)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.47
HRH1 P35367 3/20 0.47
SLC6A4 P31645 4/20 0.45
HRH3 Q9Y5N1 1/20 0.45
SLC6A2 P23975 3/20 0.44
SLC6A9 P48067 1/20 0.43
POLQ O75417 1/20 0.42
OPRK1 P41145 2/20 0.40
CHRM2 P08172 2/20 0.38
SCN1A P35498 2/20 0.38
SCN2A Q99250 2/20 0.38
SCN3A Q9NY46 2/20 0.38
UTS2R Q9UKP6 1/20 0.37
IDO1 P14902 2/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ACHE P22303 1/20 0.37
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM4 P08173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9857222 0.87 HTR2A (0.49) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9857001 0.83 SLC6A4 (0.40) SLC6A4HRH3SLC6A2UTS2RPPARG
SCHEMBL9856580 0.81 HTR2A (0.43) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9856513 0.81 TAAR1 (0.53) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9856925 0.80 HTR2A (0.47) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9856891 0.79 HTR2A (0.53) HTR2AHRH1SLC6A4SLC6A2SLC6A9
SCHEMBL9857086 0.79 HTR2A (0.53) HTR2AHRH1SLC6A4SLC6A2OPRK1
SCHEMBL9856563 0.78 TAAR1 (0.53) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9856826 0.78 TAAR1 (0.53) HTR2AHRH1SLC6A4HRH3SLC6A2
SCHEMBL9857350 0.77 SLC6A9 (0.67) HTR2AHRH1SLC6A4HRH3SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed